Short description of company. Example from Generex site: NuGenerex Immuno-Oncology (formerly Antigen Express) is developing novel immunotherapy & vaccine formulations based upon the Company’s Ii- Key hybrid peptides and Ii- Suppression technology. NuGenerex has a pipeline of immunotherapeutics that spans multiple therapeutic areas including oncology, infectious diseases, and autoimmune disorders. Our lead product, AE37, incorporates our li-peptide linker to a designated antigen to activate the immune-system to target specific cancer cells. Phase I clinical data in patients with both breast and prostate cancer show AE37 was able to stimulate immune-regulatory agents without the need for adjuvant.
Latest News |